New diabetes clinical trial: Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency

Published on: September 15, 2022 at 11:00AM
Condition:   Diabetes Mellitus, Type 1
Interventions:   Drug: Dapagliflozin 10 MG [Farxiga];   Device: Biosense Breath Ketone Analyzer
Sponsors:   Washington University School of Medicine;   Juvenile Diabetes Research Foundation
Not yet recruiting
https://ift.tt/dma9T01